DRAGONI, FILIPPO
DRAGONI, FILIPPO
Dipartimento di Biotecnologie Mediche
Antiviral drug development for treatment of acute and chronic viral infections
2021-01-01 Dragoni, Filippo
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects
2021-01-01 Vicenti, I.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Basso, M.; Dragoni, F.; Parisi, S. G.; Zazzi, M.
Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human Sperm
2022-01-01 Luddi, Alice; Luongo, Francesca Paola; Dragoni, Filippo; Fiaschi, Lia; Vicenti, Ilaria; Lupetti, Pietro; Gentile, Mariangela; Paccagnini, Eugenio; Haxhiu, Alesandro; Ponchia, Rosetta; Governini, Laura; Zazzi, Maurizio; Piomboni, Paola
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations
2020-01-01 Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Dragoni, Filippo; Appendino, Alice; Albanesi, Edoardo; Vicenti, Ilaria; Zazzi, Maurizio
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
2022-01-01 Vicenti, Ilaria; Basso, Monica; Dragoni, Filippo; Gatti, Francesca; Scaggiante, Renzo; Fiaschi, Lia; Parisi, Saverio G; Zazzi, Maurizio
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
2018-01-01 Vicenti, Ilaria; Boccuto, Adele; Giannini, Alessia; Dragoni, Filippo; Saladini, Francesco; Zazzi, Maurizio
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected
2021-01-01 Gidari, A.; Sabbatini, S.; Bastianelli, S.; Pierucci, S.; Busti, C.; Monari, C.; Luciani Pasqua, B.; Dragoni, F.; Schiaroli, E.; Zazzi, M.; Francisci, D.
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals
2021-01-01 Boccuto, A.; Dragoni, F.; Bergna, A.; Ventura, C. D.; Giammarino, F.; Saladini, F.; Pezzati, L.; Zehender, G.; Zazzi, M.; Vicenti, I.; Lai, A.
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication.
2020-01-01 Vicenti, I; Dragoni, F; Giannini, A; Giammarino, F; Spinicci, M; Saladini, F; Boccuto, A; Zazzi, M.
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy
2022-01-01 Dragoni, Filippo; Rossetti, Barbara; Lombardi, Francesca; Raffaelli, Chiara Spertilli; Bartolini, Niccolò; Giammarino, Federica; Moschese, Davide; Di Giambenedetto, Simona; Fabbiani, Massimiliano; De Luca, Andrea; Vicenti, Ilaria; Zazzi, Maurizio; Saladini, Francesco
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
2022-01-01 Fiaschi, L.; Dragoni, F.; Schiaroli, E.; Bergna, A.; Rossetti, B.; Giammarino, F.; Biba, C.; Gidari, A.; Lai, A.; Nencioni, C.; Francisci, D.; Zazzi, M.; Vicenti, I.
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro.
2020-01-01 Dragoni, F; Boccuto, A; Picarazzi, F; Giannini, A; Giammarino, F; Saladini, F; Mori, M; Mastrangelo, E; Zazzi, M; Vicenti, I.
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
2022-01-01 Vicenti, Ilaria; Dragoni, Filippo; Giannini, Alessia; Casabianca, Anna; Lombardi, Francesca; Di Sante, Laura; Turriziani, Ombretta; Racca, Sara; Paolucci, Stefania; Lai, Alessia; Bon, Isabella; Abbate, Isabella; Rozera, Gabriella; Belmonti, Simone; Scutari, Rossana; Alteri, Claudia; Saladini, Francesco; Zazzi, Maurizio
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
2021-01-01 Vicenti, Ilaria; Basso, Monica; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Modolo, Eliana; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies
2022-01-01 Dragoni, Filippo; Schiaroli, Elisabetta; Micheli, Valeria; Fiaschi, Lia; Lai, Alessia; Zehender, Gianguglielmo; Rossetti, Barbara; Gismondo, Maria Rita; Francisci, Daniela; Zazzi, Maurizio; Vicenti, Ilaria
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study
2021-01-01 Cirri, D.; Marzo, T.; Tolbatov, I.; Marrone, A.; Saladini, F.; Vicenti, I.; Dragoni, F.; Boccuto, A.; Messori, L.
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations
2021-01-01 Saladini, F.; Giammarino, F.; Hosseini, B. A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Vicenti, I.; Shafer, R. W.; Zazzi, M.
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir
2021-01-01 Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
2022-01-01 Parisi, Saverio Giuseppe; Mengoli, Carlo; Basso, Monica; Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Fiaschi, Lia; Giammarino, Federica; Iannetta, Marco; Malagnino, Vincenzo; Zago, Daniela; Dragoni, Filippo; Zazzi, Maurizio
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells
2021-01-01 Vicenti, Ilaria; Dragoni, Filippo; Monti, Martina; Trombetta, Claudia Maria; Giannini, Alessia; Boccuto, Adele; Saladini, Francesco; Rossetti, Barbara; De Luca, Andrea; Ciabattini, Annalisa; Pastore, Gabiria; Medaglini, Donata; Orofino, Giancarlo; Montomoli, Emanuele; Zazzi, Maurizio
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Antiviral drug development for treatment of acute and chronic viral infections | 1-gen-2021 | Dragoni, Filippo | - | |
| BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects | 1-gen-2021 | Vicenti, I.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Basso, M.; Dragoni, F.; Parisi, S. G.; Zazzi, M. | - | |
| Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human Sperm | 1-gen-2022 | Luddi, Alice; Luongo, Francesca Paola; Dragoni, Filippo; Fiaschi, Lia; Vicenti, Ilaria; Lupetti, Pietro; Gentile, Mariangela; Paccagnini, Eugenio; Haxhiu, Alesandro; Ponchia, Rosetta; Governini, Laura; Zazzi, Maurizio; Piomboni, Paola | - | |
| Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations | 1-gen-2020 | Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Dragoni, Filippo; Appendino, Alice; Albanesi, Edoardo; Vicenti, Ilaria; Zazzi, Maurizio | - | |
| Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection | 1-gen-2022 | Vicenti, Ilaria; Basso, Monica; Dragoni, Filippo; Gatti, Francesca; Scaggiante, Renzo; Fiaschi, Lia; Parisi, Saverio G; Zazzi, Maurizio | - | |
| Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro | 1-gen-2018 | Vicenti, Ilaria; Boccuto, Adele; Giannini, Alessia; Dragoni, Filippo; Saladini, Francesco; Zazzi, Maurizio | - | |
| Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected | 1-gen-2021 | Gidari, A.; Sabbatini, S.; Bastianelli, S.; Pierucci, S.; Busti, C.; Monari, C.; Luciani Pasqua, B.; Dragoni, F.; Schiaroli, E.; Zazzi, M.; Francisci, D. | - | |
| Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals | 1-gen-2021 | Boccuto, A.; Dragoni, F.; Bergna, A.; Ventura, C. D.; Giammarino, F.; Saladini, F.; Pezzati, L.; Zehender, G.; Zazzi, M.; Vicenti, I.; Lai, A. | - | |
| Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. | 1-gen-2020 | Vicenti, I; Dragoni, F; Giannini, A; Giammarino, F; Spinicci, M; Saladini, F; Boccuto, A; Zazzi, M. | - | |
| Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy | 1-gen-2022 | Dragoni, Filippo; Rossetti, Barbara; Lombardi, Francesca; Raffaelli, Chiara Spertilli; Bartolini, Niccolò; Giammarino, Federica; Moschese, Davide; Di Giambenedetto, Simona; Fabbiani, Massimiliano; De Luca, Andrea; Vicenti, Ilaria; Zazzi, Maurizio; Saladini, Francesco | - | |
| Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 | 1-gen-2022 | Fiaschi, L.; Dragoni, F.; Schiaroli, E.; Bergna, A.; Rossetti, B.; Giammarino, F.; Biba, C.; Gidari, A.; Lai, A.; Nencioni, C.; Francisci, D.; Zazzi, M.; Vicenti, I. | - | |
| Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. | 1-gen-2020 | Dragoni, F; Boccuto, A; Picarazzi, F; Giannini, A; Giammarino, F; Saladini, F; Mori, M; Mastrangelo, E; Zazzi, M; Vicenti, I. | - | |
| External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy | 1-gen-2022 | Vicenti, Ilaria; Dragoni, Filippo; Giannini, Alessia; Casabianca, Anna; Lombardi, Francesca; Di Sante, Laura; Turriziani, Ombretta; Racca, Sara; Paolucci, Stefania; Lai, Alessia; Bon, Isabella; Abbate, Isabella; Rozera, Gabriella; Belmonti, Simone; Scutari, Rossana; Alteri, Claudia; Saladini, Francesco; Zazzi, Maurizio | - | |
| Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose | 1-gen-2021 | Vicenti, Ilaria; Basso, Monica; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Modolo, Eliana; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio | - | |
| Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies | 1-gen-2022 | Dragoni, Filippo; Schiaroli, Elisabetta; Micheli, Valeria; Fiaschi, Lia; Lai, Alessia; Zehender, Gianguglielmo; Rossetti, Barbara; Gismondo, Maria Rita; Francisci, Daniela; Zazzi, Maurizio; Vicenti, Ilaria | - | |
| In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study | 1-gen-2021 | Cirri, D.; Marzo, T.; Tolbatov, I.; Marrone, A.; Saladini, F.; Vicenti, I.; Dragoni, F.; Boccuto, A.; Messori, L. | - | |
| In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations | 1-gen-2021 | Saladini, F.; Giammarino, F.; Hosseini, B. A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Vicenti, I.; Shafer, R. W.; Zazzi, M. | - | |
| In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir | 1-gen-2021 | Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio | - | |
| Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses | 1-gen-2022 | Parisi, Saverio Giuseppe; Mengoli, Carlo; Basso, Monica; Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Fiaschi, Lia; Giammarino, Federica; Iannetta, Marco; Malagnino, Vincenzo; Zago, Daniela; Dragoni, Filippo; Zazzi, Maurizio | - | |
| Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells | 1-gen-2021 | Vicenti, Ilaria; Dragoni, Filippo; Monti, Martina; Trombetta, Claudia Maria; Giannini, Alessia; Boccuto, Adele; Saladini, Francesco; Rossetti, Barbara; De Luca, Andrea; Ciabattini, Annalisa; Pastore, Gabiria; Medaglini, Donata; Orofino, Giancarlo; Montomoli, Emanuele; Zazzi, Maurizio | - |